<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122719">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01929772</url>
  </required_header>
  <id_info>
    <org_study_id>12-052</org_study_id>
    <nct_id>NCT01929772</nct_id>
  </id_info>
  <brief_title>German Lactat Clearance in Severe Sepsis</brief_title>
  <acronym>GLASS</acronym>
  <official_title>German Lactat Clearance in Severe Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate if there is a correlation between lactate clearance
      and the course at patients with severe sepsis and septic shock at german intensive care
      units.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Lactate Clearance</measure>
    <time_frame>Within 6 hours after diagnoses</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determination of lactate clearance within 6 hours after diagnosis of severe sepisis and septic shocik</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SOFA Score</measure>
    <time_frame>Day of hospitalization, day 7, day 8</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Mortality</measure>
    <time_frame>After 28 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determination of the mortality of the collective after 28 days</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration intensive care unit and hospitalization</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>severe sepsis or septic shock</arm_group_label>
    <description>patients with severe sepsis or septic shock</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe sepsis or septic shock
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with severe sepsis or septic shock

          -  signed informed consent

        Exclusion Criteria:

          -  severe sepsis or septic schock within 4 weeks before inclusion of study

          -  shock of other genesis

          -  persons being accomondated in an institution because of court or official    order

          -  persons being interdependet to the investigator

          -  employees of the investigator
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Fries, M.D.</last_name>
    <phone>+49 241 80 88179</phone>
    <email>mfries@ukaachen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department for Operative Intensive Care and Intermediate Care - University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <state>North Rhine Westfalia</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fries, M.D.</last_name>
      <phone>+49 241 80 88179</phone>
      <email>mfries@ukaachen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 21, 2013</lastchanged_date>
  <firstreceived_date>August 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
